The orthopaedic literature abounds with descriptions of implantable devices and instruments that have failed for one reason or another. Increased awareness of these problems can help orthopaedists prevent similar mishaps in the future, enhancing patient outcomes. But what happens when hospital-specified, -purchased, and -owned equipment fails? How is information about such failures distributed within the hospital and to the orthopaedic community at large? Which parties—doctors, OR staff, manufacturers, or hospital administrators—should assume responsibility for reporting these failures to the FDA to prevent patient harm? This month’s “Case Connections,” springboarding from a case report about a failed trauma table in the March 9, 2016, edition of JBJS Case Connector, addresses those questions. Andrews et al. describe the case of a 66-year-old morbidly obese woman who, during open reduction and internal fixation of an intertrochanteric femoral fracture, slid into a reclined seated position because of a material failure in the spar tube of a Mizuho OSI orthopaedic trauma table (model #5855). The table in question has a rated capacity of 227 kg (500 lb), and the patient weighed 168 kg (370 lb). The table top failed suddenly during wound closure, and the patient was suspended on the broken frame about 1 foot off the ground. She was carefully moved onto a backboard and lifted onto a second OSI table that had been inspected and brought into the OR. Intraoperative fluoroscopy and postoperative screening CT were negative for additional skeletal injury. Aside from the table malfunction, the surgery was successful. The patient and her family were counseled immediately after the procedure on what had transpired. At the 3-week follow-up visit, the patient’s wounds were well healed, and by 6 weeks …